Severity of the COVID-19 pandemic assessed with all-cause mortality in
the United States during 2020.
- Fredrick Dahlgren,
- Lauren Rossen,
- Alicia Fry,
- Carrie Reed
Fredrick Dahlgren
Centers for Disease Control and Prevention
Corresponding Author:fdahlgr@gmail.com
Author ProfileAbstract
Background. In the United States, infection with SARS-CoV-2 caused
380,000 reported deaths from March to December 2020. Methods. We adapted
the Moving Epidemic Method to all-cause mortality data from the United
States to assess the severity of the COVID-19 pandemic across age groups
and all 50 states. By comparing all-cause mortality during the pandemic
with intensity thresholds derived from recent, historical all-cause
mortality, we categorized each week from March to December 2020 as
either low severity, moderate severity, high severity, or very high
severity. Results. Nationally for all ages combined, all-cause mortality
was in the very high severity category for 9 weeks. Among people 18 to
49 years of age, there were 29 weeks of consecutive very high severity
mortality. Forty-seven states, the District of Columbia, and New York
City each experienced at least one week of very high severity mortality
for all ages combined. Conclusions. These periods of very high severity
of mortality during March through December 2020 are likely directly or
indirectly attributable to the COVID-19 pandemic. This method for
standardized comparison of severity over time across different
geographies and demographic groups provides valuable information to
understand the impact of the COVID-19 pandemic and to identify specific
locations or subgroups for deeper investigations into differences in
severity.12 Aug 2021Submitted to Influenza and other respiratory viruses 13 Aug 2021Submission Checks Completed
13 Aug 2021Assigned to Editor
15 Aug 2021Reviewer(s) Assigned
25 Sep 2021Review(s) Completed, Editorial Evaluation Pending
25 Sep 2021Editorial Decision: Revise Minor
26 Sep 20211st Revision Received
27 Sep 2021Submission Checks Completed
27 Sep 2021Assigned to Editor
28 Sep 2021Editorial Decision: Accept
May 2022Published in Influenza and Other Respiratory Viruses volume 16 issue 3 on pages 411-416. 10.1111/irv.12923